Rheumatic Disease Clinics of North America

Article	Citations
Racial/Ethnic, Socioeconomic, and Geographic Disparities in the Epidemiology of Knee and Hip Osteoarthritis	42
Risk Factors and Cancer Screening in Myositis	29
Rheumatoid Arthritis	26
Osteoarthritis Treatment Guidelines from Six Professional Societies	26
Racial/Ethnic and Socioeconomic Disparities in Osteoarthritis Management	25
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis	24
Treatment Guidelines in Rheumatoid Arthritis	23
Gender and Ethnic Inequities in Gout Burden and Management	23
Basic Mechanisms of Pain in Osteoarthritis	22
Cancer and Systemic Lupus Erythematosus	22
Axial Psoriatic Arthritis	22
Understanding Lupus Disparities Through a Social Determinants of Health Framework	21
Cancer and Rheumatoid Arthritis	20
Systemic Lupus Erythematosus Classification and Diagnosis	16
COVID-19 in Pediatrics	15
Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries	14
Cancer and Scleroderma	14
Socioeconomic Status, Health Care, and Outcomes in Systemic Lupus Erythematosus	14
Classification Criteria in Axial Spondyloarthritis	14
(Health-Related) Quality of Life as an Outcome in Studies of Axial Spondyloarthritis	13
Recent Updates in Juvenile Spondyloarthritis	13
Health Disparities in Systemic Lupus Erythematosus	13
Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms	12
Targeting Nerve Growth Factor for Pain Management in Osteoarthritis—Clinical Efficacy and Safety	12
Juvenile Localized Scleroderma	12

B Cells in Systemic Lupus Erythematosus	12
Neutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus	12
Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus	12
Risk of Malignancy in Spondyloarthritis	12
Racial Disparities in Systemic Sclerosis	11
Racial Disparities in Rheumatology Through the Lens of Critical Race Theory	11
Juvenile-Versus Adult-Onset Spondyloarthritis	10
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus	10
Sjögren Syndrome and Cancer	10
Treat to Target in Axial Spondyloarthritis	10
Low Back Pain in Adolescent and Geriatric Populations	9
The Power of Systems Biology	9
Interferons in Systemic Lupus Erythematosus	9
Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity	9
Intestinal Microbiota, HLA-B27, and Spondyloarthritis	8
Juvenile Idiopathic Arthritis Treatment Updates	8
Pathogenesis of Axial Spondyloarthritis — Sources and Current State of Knowledge	8
Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes	8
The Categorization of Pain in Systemic Lupus Erythematosus	8
Recommendations for Systemic Lupus Erythematosus	8
Health Disparities in Rheumatic Diseases	7
Disparities in Pediatric Rheumatic Diseases	7
The Temporomandibular Joint in Juvenile Idiopathic Arthritis	7
Systemic Autoinflammatory Diseases	7
Mental Health in Pediatric Rheumatology	7
T Cells in Systemic Lupus Erythematosus	7
Disparities in Childhood-Onset Lupus	7
Paraneoplastic Musculoskeletal Syndromes	7
Uveitis in Children and Adolescents	7
Pain Mechanisms in Patients with Rheumatic Diseases	7
Chronic Nonbacterial Osteomyelitis	6
What Does Human Leukocyte Antigen B27 Have to Do with Spondyloarthritis?	6
Behçet Syndrome	6
Designing an Intervention to Improve Management of High-Risk Lupus Patients Through Care Coordination	6
Leveraging Telemedicine as an Approach to Address Rheumatic Disease Health Disparities	6
Pain in Axial Spondyloarthritis	6
Treatment Update in Systemic Lupus Erythematous	6
Unique Aspects of Pediatric Sjögren Disease	6
Why It Hurts	6
Understanding Risk Factors for Poor Outcomes in a Multiethnic Longitudinal Cohort	6
Understanding the Disproportionate Burden of Rheumatic Diseases in Indigenous North American Populations	6
Emerging Imaging Techniques in Spondyloarthritis	6
Environmental Triggers of Hyperuricemia and Gout	6
Management of Pregnancy in Lupus	6
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	5
Pharmacosurveillance in Juvenile Idiopathic Arthritis	5
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	5
Ultrasonography in Pediatric Rheumatology	5
Juvenile Fibromyalgia	5
Fibromyalgia	5

The Contribution of Genetics and Epigenetics to Our Understanding of Health Disparities in Rheumatic Diseases	5
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	5
Sexual Dimorphism in the Expression of Pain Phenotype in Preclinical Models of Rheumatoid Arthritis	4
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model	4
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy	4
The Patient’s Perspective on the Burden of Disease in Ankylosing Spondylitis	4
Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials	4
Treatment Guidelines in Vasculitis	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	4
Axial Spondyloarthritis in the Era of Precision Medicine	4
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development	4
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	4
The Future of Imaging in Axial Spondyloarthritis	3
Molecular Biology Approaches to Understanding Spondyloarthritis	3
The GRADE Method	3
Immune Checkpoint Inhibition—Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity	3
Increasing Ancestral Diversity in Lupus Trials	3
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	3
CARRA	3
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	3
The Future of Axial Spondyloathritis Treatment	3
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis	3
Environmental Risks for Spondyloarthropathies	3
Management of Knee Osteoarthritis	3
Managing Cardiovascular Risk in Patients with Rheumatic Disease	3
Can Imaging Be a Proxy for Remission in Axial Spondyloarthritis?	3
Using the Electronic Health Record to Enhance Care in Pediatric Rheumatology	3
Treatment Guidelines in Gout	3
Rheumatic Complications of Immune Checkpoint Inhibitors	3
Giant Cell Arteritis and Polymyalgia Rheumatica	3
Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases:	3
Interstitial Lung Disease	3
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	3
Management and Cure of Gouty Arthritis	3
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	3
Nonpharmacologic Pain Management in Inflammatory Arthritis	3
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	2
Environmental Risks for Inflammatory Myopathies	2
Transitioning to Adulthood with a Rheumatic Disease	2
Central Nervous System Vasculitis	2
Innovative Trials and New Opportunities in SLE	2
Patient Experience of Systemic Sclerosis–Related Calcinosis	2
Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome	2
Patient Engagement in Pediatric Rheumatology Research	2
Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis	2
Systemic Lupus Erythematosus Risk	2
AS Patient	2
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis	2
Inhalant and Additional Mucosal-Related Environmental Risks for Rheumatoid Arthritis	2
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	2
Treatment of Vascular Complications in Systemic Sclerosis	2
Spondyloarthritis: The Changing Landscape—Are We There Yet?	2
Vasculitis and Pregnancy	2
Community-Engaged Research: Leveraging Community-Academic Partnerships to Reduce Disparities and Inequities in Lupus Care	2
Recent Advances in Pediatric Vasculitis	2
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	2
Gastrointestinal Tract Considerations: Part II	2
Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease	2
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica	2
Overview of the Associations Between Cancer and Rheumatic Disease	2
The Promises and Perils of Social Media for Pediatric Rheumatology	2
Gastrointestinal Tract Considerations Part I	2
Precision Medicine	2
Statin-Associated Myalgias and Muscle Injury—Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein	1
Genetic Defects in Early-Onset Inflammatory Bowel Disease	1
The Exciting Future for Scleroderma	1
Understanding the Role and Challenges of Patient Preferences in Disparities in Rheumatologic Disease Care	1
The Emerging Telehealth Landscape in Pediatric Rheumatology	1
NF-κB and Related Autoimmune and Autoinflammatory Diseases	1
Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy	1
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases	1
Taxonomy of Quality of Care Indicators	1
Systemic Lupus Erythematosus: The Next Generation of Ideas and Scientists	1
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis	1
Patient-Reported Outcomes in Lupus	1
Heart Failure in Rheumatic Disease	1
Health Disparities in Rheumatic Diseases: Part II	1
Treatment of Inflammatory Arthritis in Systemic Sclerosis	1
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis	1

Health Care Utilization	1
Cannabinoids and Pain	1
Environmental Risks for Systemic Sclerosis	1
Role of Environment in Pediatric Rheumatic Diseases	1
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	1
Perioperative Management of Rheumatic Disease and Therapies	1
Pulmonary Hypertension	1
How the American College of Rheumatology Develops Guidelines	1
Lupus Cohorts	1
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases	1
Environmental Triggers for Vasculitis	1
Health Disparities in Rheumatic Diseases: Part I	1
Forthcoming Issues	0
Copyright	0
Copyright	0
Pediatric Rheumatic Disease in Lower to Middle-Income Countries	0
Contents	0
Pediatric Rheumatology Comes of Age: Part II	0
Issue 1	0
Outcome Measures in Pediatric Rheumatic Disease	0
Gerald P Rodnan	0
J. Claude Bennett, MD	0
Forthcoming Issues	0
Environmental Triggers for Rheumatic Diseases	0
Copyright	0
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	0
Best Approaches to the Care of Systemic Sclerosis Patients	0
Contents	0
Contributors	0
Copyright	0
Preexisting Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression	0
Copyright	0
Contributors	0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology	0
Eric Bywaters and Barbara Ansell	0
Contents	0
Contents	0
Copyright	0
Contributors	0
Foreword	0
Contributors	0
Foreword	0
Inflammatory Arthritis due to Immune Checkpoint Inhibitors	0
Targeting Environmental Risks to Prevent Rheumatic Disease	0
Rheumatic Disease Clinics of North America	0
Copyright	0
Rheumatic Disease Clinics of North America	0
Impact of Nonsteroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Antirheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	0
Contributors	0
Preface	0
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	0
Forthcoming Issues	0
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	0
Copyright	0
COPA Syndrome from Diagnosis to Treatment	0
Contributors	0
Copyright	0
Approach to Diagnosing Inborn Errors of Immunity	0
Cancer and Rheumatic Diseases	0
Edmund Lawrence Dubois (1923–1985)	0
Copyright	0
Contributors	0
Expanding IPEX: Inborn Errors of Regulatory T Cells	0
Treatment Guidelines in Pediatric Rheumatic Diseases	0
Health Disparities in Rheumatic Diseases - Issue 2	0
Copyright	0
Copyright	0
Pain in Rheumatic Diseases	0
Isolated Aortitis	0
Contents	0
Pediatric Rheumatology Comes of Age: Part I	0
H. Ralph Schumacher	0
Contributors	0
Contributors	0
Deficiency of Adenosine Deaminase 2	0
Patient Voices in Rheumatic Immune-Related Adverse Events	0
Hal Holman of Stanford	0
Contents	0
Nathan Zvaifler	0
Contents	0
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	0
Copyright	0
Timely Knowledge and Clinical Insights on Cancer and Rheumatic Disease	0
Forthcoming Issues	0
Contents	0
Contents	0
Approach to Systemic Sclerosis Patient Assessment	0
Contributors	0
The Giants Of Rheumatology	0
Forthcoming Issues	0
Pediatric Rheumatology Comes of Age: Part I	0
Contents	0
Pain in Rheumatic Diseases	0
Copyright	0
Contents	0